{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:51Z","timestamp":1787030571626,"version":"build-2736575974"},"reference-count":28,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15065","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T08:18:41Z","timestamp":1745828321000},"page":"1-5","source":"Crossref","is-referenced-by-count":3,"title":["Chronic myeloid leukemia with the e13a3 atypical fusion gene: A case report"],"prefix":"10.3892","volume":"29","author":[{"given":"Xin","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ran","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Ning","family":"Shan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"key20250513102215_b1-ol-29-6-15065","first-page":"e21077","article-title":"The progression of chronic myeloid leukemia to myeloid sarcoma: A systematic review","volume":"14","author":"Arzoun","year":"2022","journal-title":"Cureus"},{"key":"key20250513102215_b2-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"e0202429","DOI":"10.1371\/journal.pone.0202429","article-title":"Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes","volume":"13","author":"Tsuchiya","year":"2018","journal-title":"PLoS One"},{"key":"key20250513102215_b3-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"29906","DOI":"10.18632\/oncotarget.15369","article-title":"Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: Molecular cytogenetic characterization and influence on TKIs therapy","volume":"8","author":"Luatti","year":"2017","journal-title":"Oncotarget"},{"key":"key20250513102215_b4-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.3390\/ijms222212516","article-title":"Genetic biomarkers in chronic myeloid leukemia: What have we learned so far?","volume":"22","author":"Abdulmawjood","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20250513102215_b5-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","article-title":"Chronic myeloid leukemia: The paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy","volume":"17","author":"Soverini","year":"2018","journal-title":"Mol Cancer"},{"key":"key20250513102215_b6-ol-29-6-15065","first-page":"28","article-title":"An uncommon case of chronic myeloid leukemia with variant cytogenetic","volume":"89","author":"Abdullah","year":"2018","journal-title":"Acta Biomed"},{"key":"key20250513102215_b7-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"15","DOI":"10.38094\/jlbsr40172","article-title":"A short review about chronic myeloid leukemia","volume":"4","author":"Al-Bayati","year":"2023","journal-title":"J Life Bio Sci Res"},{"key":"key20250513102215_b8-ol-29-6-15065","first-page":"1182","article-title":"Integrated genomic analysis identifies ANKRD36 gene as a novel and common biomarker of disease progression in chronic myeloid leukemia","volume":"10","author":"Iqbal","year":"2021","journal-title":"Biology (Basel)"},{"key":"key20250513102215_b9-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.leukres.2007.08.017","article-title":"A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts","volume":"32","author":"Burmeister","year":"2008","journal-title":"Leuk Res"},{"key":"key20250513102215_b10-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1080\/10428194.2019.1607329","article-title":"Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts","volume":"60","author":"Xue","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"key20250513102215_b11-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"e2020062","DOI":"10.4084\/mjhid.2020.062","article-title":"Prognostic significance of transcript-Type BCR-ABL1 in chronic myeloid leukemia","volume":"12","author":"Molica","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"key20250513102215_b12-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s00432-021-03569-8","article-title":"Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: Recommendations by the EUTOS cooperative network","volume":"147","author":"Sch\u00e4fer","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20250513102215_b13-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"8486267","DOI":"10.1155\/2024\/8486267","article-title":"A novel BCR::ABL1 variant detected with multiple testing modalities","volume":"2024","author":"Jean","year":"2024","journal-title":"Case Rep Hematol"},{"key":"key20250513102215_b14-ol-29-6-15065","first-page":"9635070","article-title":"Molecular monitoring in adult philadelphia chromosome-positive acute lymphoblastic leukemia with the variant e13a3 BCR-ABL1 fusion","volume":"2019","author":"Crampe","year":"2019","journal-title":"Case Rep Hematol"},{"key":"key20250513102215_b15-ol-29-6-15065","first-page":"5619","article-title":"How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review","volume":"14","author":"Hu","year":"2017","journal-title":"Oncol Lett"},{"key":"key20250513102215_b16-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"e36728","DOI":"10.1097\/MD.0000000000036728","article-title":"Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review","volume":"103","author":"Li","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"key20250513102215_b17-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/cells12081135","article-title":"Gene fusion detection in NSCLC routine clinical practice: Targeted-NGS or FISH?","volume":"12","author":"Pecciarini","year":"2023","journal-title":"Cells"},{"key":"key20250513102215_b18-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3949\/ccjm.88a.19148","article-title":"Precision treatment for metastatic non-small cell lung cancer: A conceptual overview","volume":"88","author":"Lee","year":"2021","journal-title":"Cleve Clin J Med"},{"key":"key20250513102215_b19-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1111\/cas.15501","article-title":"Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia","volume":"113","author":"Su","year":"2022","journal-title":"Cancer Sci"},{"key":"key20250513102215_b20-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000445676","article-title":"Nilotinib-induced keratosis pilaris","volume":"8","author":"Leong","year":"2016","journal-title":"Case Rep Dermatol"},{"key":"key20250513102215_b21-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41375-023-02048-y","article-title":"European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia","volume":"37","author":"Cross","year":"2023","journal-title":"Leukemia"},{"key":"key20250513102215_b22-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"78","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-1.14300","article-title":"Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia","volume":"42","author":"Kearney","year":"2020","journal-title":"Exp Oncol"},{"key":"key20250513102215_b23-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3904\/kjim.2015.187","article-title":"BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J Intern Med"},{"key":"key20250513102215_b24-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/medicina60071092","article-title":"Scleroderma-like lesions in a patient undergoing combined pembrolizumab and routine chemotherapy: A case report and literature review","volume":"60","author":"Pai","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"key20250513102215_b25-ol-29-6-15065","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2025.01.014","article-title":"Long-term outcomes of chronic myeloid leukemia in children and adolescents-real world data from a single-institute in Taiwan","author":"Yang","year":"2025","journal-title":"J Formos Med Assoc"},{"key":"key20250513102215_b26-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.12659\/AJCR.904956","article-title":"Dasatinib and azacitidine followed by haploidentical stem cell transplant for chronic myeloid leukemia with evolving myelodysplasia: A case report and review of treatment options","volume":"18","author":"Lang","year":"2017","journal-title":"Am J Case Rep"},{"key":"key20250513102215_b27-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/s41375-024-02314-7","article-title":"The e13a3 (b2a3) and e14a3 (b3a3) BCR::ABL1 isoforms are resistant to asciminib","volume":"38","author":"Leske","year":"2024","journal-title":"Leukemia"},{"key":"key20250513102215_b28-ol-29-6-15065","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/CMAR.S353374","article-title":"Asciminib in the treatment of philadelphia chromosome-positive chronic myeloid leukemia: Focus on patient selection and outcomes","volume":"15","author":"Hijiya","year":"2023","journal-title":"Cancer Manag Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T03:22:22Z","timestamp":1747106542000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,28]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15065","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}